Home › Funds › Performa Ltd (US), LLC › MRVI
Performa Ltd (US), LLC position in MRVI
MARAVAI LIFESCIENCES HLDGS I · Health Care
Performa Ltd (US), LLC reported holding 2,000 shares of MRVI (MARAVAI LIFESCIENCES HLDGS I) in its Q3 2026 13F filing — a position valued at US$15K, representing 0.00% of its reported portfolio and ranking #29 among its reported holdings. Performa Ltd (US), LLC has disclosed MRVI holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Performa Ltd (US), LLC's MRVI position evolved
Performa Ltd (US), LLC first disclosed a stake in MRVI in Q3 2023 at 2,825 shares (US$28K). The position peaked in Q1 2024 at 6,750 shares, worth US$59K. Across 13 filings, Performa Ltd (US), LLC increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 2,000 shares valued at US$15K. Notable position changes include a 180% increase in Q3 2024 (shares fell 34% over the following quarter), a 614% increase in Q4 2024 (shares fell 59% over the following quarter), a 245% increase in Q1 2025 (shares rose 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.83K | $28.25K | New |
| Q4 2023 | 6.00K | $39.30K | Add |
| Q1 2024 | 6.75K | $58.52K | Add |
| Q2 2024 | 250 | $1.79K | Reduce |
| Q3 2024 | 700 | $5.82K | Add |
| Q4 2024 | 5.00K | $27.25K | Add |
| Q1 2025 | 17.25K | $38.12K | Add |
| Q2 2025 | 22.99K | $55.41K | Add |
| Q3 2025 | 16.65K | $47.79K | Reduce |
| Q4 2025 | 3.31K | $10.77K | Reduce |
| Q1 2026 | 2.75K | $7.78K | Reduce |
| Q2 2026 | 2.00K | $12.48K | Reduce |
| Q3 2026 | 2.00K | $15.32K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MRVI and 13F data
MRVI (MARAVAI LIFESCIENCES HLDGS I) is a Health Care company. 36 other funds we track also report a position in MRVI — the largest reported positions include GTCR LLC (US$125.7M), BRAIDWELL LP (US$54.3M), 12 West Capital Management LP (US$44.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MRVI
- GTCR LLC 20.15M sh · $125.74M · Q2 2026
- BRAIDWELL LP 8.70M sh · $54.31M · Q2 2026
- 12 West Capital Management LP 7.06M sh · $44.06M · Q2 2026
- Ophir Asset Management Pty Ltd 4.83M sh · $30.12M · Q2 2026
- GENERAL AMERICAN INVESTORS CO INC 1.72M sh · $13.15M · Q3 2026
- Philosophy Capital Management LLC 1.90M sh · $11.86M · Q2 2026
More on Performa Ltd (US), LLC
FAQ
How long has Performa Ltd (US), LLC held MRVI?
Performa Ltd (US), LLC has disclosed MRVI holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Performa Ltd (US), LLC's current position in MRVI?
As of Q3 2026, Performa Ltd (US), LLC holds 2.00K shares of MRVI (MARAVAI LIFESCIENCES HLDGS I), valued at $15.32K, representing 0.00% of its reported portfolio and ranking #29.
Has Performa Ltd (US), LLC been buying or selling MRVI?
In the latest 13F filing (Q3 2026), Performa Ltd (US), LLC held unchanged its position in MRVI. The position peaked in Q1 2024 at 6.75K shares.
Which other funds hold MRVI?
Other major institutional holders of MRVI include GTCR LLC, BRAIDWELL LP, 12 West Capital Management LP, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.